Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease.

Vogel JW, Mattsson N, Iturria-Medina Y, Strandberg OT, Schöll M, Dansereau C, Villeneuve S, van der Flier WM, Scheltens P, Bellec P, Evans AC, Hansson O, Ossenkoppele R; Alzheimer's Disease Neuroimaging Initiative; Swedish BioFINDER Study.

Hum Brain Mapp. 2019 Feb 1;40(2):638-651. doi: 10.1002/hbm.24401. Epub 2018 Oct 19.

PMID:
30368979
2.

Regional times to equilibria and their impact on semi-quantification of [18F]AV-1451 uptake.

Heurling K, Smith R, Strandberg OT, Schain M, Ohlsson T, Hansson O, Schöll M.

J Cereb Blood Flow Metab. 2018 Aug 3:271678X18791430. doi: 10.1177/0271678X18791430. [Epub ahead of print]

PMID:
30073880
3.

Modeling Strategies for Quantification of In Vivo 18F-AV-1451 Binding in Patients with Tau Pathology.

Hahn A, Schain M, Erlandsson M, Sjölin P, James GM, Strandberg OT, Hägerström D, Lanzenberger R, Jögi J, Olsson TG, Smith R, Hansson O.

J Nucl Med. 2017 Apr;58(4):623-631. doi: 10.2967/jnumed.116.174508. Epub 2016 Oct 20.

Supplemental Content

Loading ...
Support Center